Business

Announcement on New Drug Indication Obtaining Registration Approval for a Holding Subsidiary

Announcement on New Drug Indication Obtaining Registration Approval for a Holding Subsidiary

Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class AJune 15, 20264
Announcement on New Drug Indication Obtaining Registration Approval for a Holding Subsidiary

About this update from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

Announcement on New Drug Indication Obtaining Registration Approval for a Holding Subsidiary The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

More from Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A

All Shanghai Fosun Pharmaceutical (group) Co., Ltd. Class A news →